SHIN NIPPON BIOMEDICAL LABORATORIES LTDSHIN NIPPON BIOMEDICAL LABORATORIES LTDSHIN NIPPON BIOMEDICAL LABORATORIES LTD

SHIN NIPPON BIOMEDICAL LABORATORIES LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪333.60 M‬EUR
‪33.87 M‬EUR
‪161.96 M‬EUR
‪19.32 M‬
Beta (1Y)
0.91

About SHIN NIPPON BIOMEDICAL LABORATORIES

CEO
Ryoichi Nagata
Website
Headquarters
Tokyo
Founded
1957
ISIN
JP3379950003
Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. Its operations are carried out through the following segments: Preclinical Business, Clinical Business, Translational Research Business, Medipolis Business, and Others. The Preclinical Business segment verifies the efficacy and safety of new drugs using experimental animals and bacterial cells. The Clinical Business segment provides the support services for clinical trials and related statistical, analytical, and consulting services for all aspects of new drug development. The Translational Research Business segment utilizes drug and device development capabilities to accelerate drug development which leads to out-licensing to pharmaceutical companies. The Medipolis Business segment deals with the property management and geothermal power generation businesses. The Others segment engages in the information collection in Europe, which includes real estate and environmental equipment operations. The company was founded in April 1957 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of YB3 is 7.95 EUR — it has decreased by 3.05% in the past 24 hours. Watch SHIN NIPPON BIOMEDICAL LABORATORIES LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SHIN NIPPON BIOMEDICAL LABORATORIES LTD stocks are traded under the ticker YB3.
YB3 stock has fallen by 7.56% compared to the previous week, the month change is a 10.67% fall, over the last year SHIN NIPPON BIOMEDICAL LABORATORIES LTD has showed a 28.38% decrease.
We've gathered analysts' opinions on SHIN NIPPON BIOMEDICAL LABORATORIES LTD future price: according to them, YB3 price has a max estimate of 16.74 EUR and a min estimate of 16.14 EUR. Watch YB3 chart and read a more detailed SHIN NIPPON BIOMEDICAL LABORATORIES LTD stock forecast: see what analysts think of SHIN NIPPON BIOMEDICAL LABORATORIES LTD and suggest that you do with its stocks.
YB3 reached its all-time high on Jan 17, 2024 with the price of 12.60 EUR, and its all-time low was 8.35 EUR and was reached on May 17, 2024. View more price dynamics on YB3 chart.
See other stocks reaching their highest and lowest prices.
YB3 stock is 3.14% volatile and has beta coefficient of 0.91. Track SHIN NIPPON BIOMEDICAL LABORATORIES LTD stock price on the chart and check out the list of the most volatile stocks — is SHIN NIPPON BIOMEDICAL LABORATORIES LTD there?
Today SHIN NIPPON BIOMEDICAL LABORATORIES LTD has the market capitalization of ‪331.98 M‬, it has decreased by 0.59% over the last week.
Yes, you can track SHIN NIPPON BIOMEDICAL LABORATORIES LTD financials in yearly and quarterly reports right on TradingView.
SHIN NIPPON BIOMEDICAL LABORATORIES LTD is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
SHIN NIPPON BIOMEDICAL LABORATORIES LTD revenue for the last quarter amounts to ‪57.79 M‬ EUR despite the estimated figure of ‪57.00 M‬ EUR. In the next quarter revenue is expected to reach ‪39.55 M‬ EUR.
YB3 net income for the last quarter is ‪10.63 M‬ EUR, while the quarter before that showed ‪5.32 M‬ EUR of net income which accounts for 99.90% change. Track more SHIN NIPPON BIOMEDICAL LABORATORIES LTD financial stats to get the full picture.
SHIN NIPPON BIOMEDICAL LABORATORIES LTD dividend yield was 3.29% in 2023, and payout ratio reached 37.63%. The year before the numbers were 1.82% and 34.35% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHIN NIPPON BIOMEDICAL LABORATORIES LTD EBITDA is ‪35.32 M‬ EUR, and current EBITDA margin is 22.80%. See more stats in SHIN NIPPON BIOMEDICAL LABORATORIES LTD financial statements.
Like other stocks, YB3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHIN NIPPON BIOMEDICAL LABORATORIES LTD stock right from TradingView charts — choose your broker and connect to your account.